With more people being exposed to antibiotics, intestinal microflora faces constant pressure of antibiotic selection, which has resulted in the emergence of multidrug resistant strains. This may pose a severe problem as intestinal Enterobacteriaceae members are commonly implicated in human infections.
Results
Twenty-four (9.9 per cent) isolates demonstrated carbapenemase activity among 242 screened Enterobacteriaceae isolates. Four stool samples had two isolates of different species, both eliciting this feature and therefore indicating presence of multiple carbapenemresistant Enterobacteriaceae (CRE) isolates in a single sample.
Conclusion
Screening for carriage of CRE in stools of patients undergoing elective or emergency gastrointestinal surgical procedures, with haematological malignancies taking chemotherapy, or those planned for bone marrow transplantation can guide clinicians about gut colonisation of multidrug-resistant Enterobacteriaceae as these groups of patients are at risk of possible endogenous infection.
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What is known about this subject?
To our knowledge, this is the first Indian study investigating the prevalence of CRE in stool samples from an urban area.
What is the key finding of this report?
This type of surveillance study can guide clinicians and clinical microbiologists about colonisation of such multidrug-resistant strains in the human gastrointestinal tract, a major reservoir of Enterobacteriaceae isolates that can act as source of infection, particularly in immunecompromised patients. 3. What are the implications for policy, research, and practice? Active surveillance is a key part in preventing the spread of drug-resistant strains as gastrointestinal carriers may serve as the reservoir for cross-transmission in the healthcare setting as well as the community.
Background
The human gastrointestinal tract is a reservoir of pathogens causing infections such as urinary tract infections (UTI), skin soft tissue infections (SSI), and nosocomial infections. 
Discussion
The emergence and spread of carbapenem-resistant Enterobacteriaceae (CRE) producing acquired carbapenemases have created a global public health crisis. 9 Knowledge about the prevalence of CRE and other drugresistant organisms in the intestine can help in formulating antibiotic policy in management of sepsis as a complication of extensive gut surgery or patients with haematological malignancy under chemotherapy or bone marrow transplantation. Das et al. mention that neonates with Gram negative bacilli in the gut had a higher incidence of clinical sepsis than those without. 10 In 50 per cent of cases, the genotypes of the organisms found in the blood were indistinguishable from their gut counterpart.
Our study had a number of limitations, including short duration and, due to lack of funding, source molecular typing of the isolates could not be performed. However, phenotypic methods were employed for the detection of CRE and, by a phenotypic confirmation method, it was found that 9.9 per cent Enterobacteriaceae isolates were CRE.
The drug-resistant organisms we have identified may remain for months in the gut of the carrier without causing any symptoms or translocate through the gut epithelium, induce healthcare-associated infections, undergo crosstransmission to other individuals, and cause limited outbreaks. 11 Active surveillance of drug-resistant strains, including extended-spectrum beta-lactamase-producing Enterobacteriaceae and carbapenem-resistant Enterobacteriaceae is an important component of any infection control program, and more surveillance studies need to be performed in India to provide a better understanding of the prevalence of drug-resistant strains as gut colonisers. Screening of drug-resistant Enterobacteriaceae can help in formulating antibiotic policy for a hospital, particularly for oncology and critically ill patients in ICUs, as these organisms can act as sources of endogenous infections.
Conclusion
Screening for carriage of CREs in stool in patients undergoing elective or emergency gastrointestinal surgical procedures, in patients with haematological malignancies taking chemotherapy, or patients with planned bone marrow transplantation can guide treating clinicians about gut colonisation of multi-drug resistant Enterobacteriaceae as these groups of patients are at risk of possible endogenous infection. This can also help in starting appropriate prophylactic antibiotics if required. Treating clinicians as well as microbiologists must be aware of the prevalence of CRE isolates in the human intestinal tract as these types of drug-resistant strains are potential sources of endogenous infections.
